Viva Biotech Holdings Financial Flexibility Index
Viva Biotech Holdings financial flexibility index. Viva Biotech Holdings (VB0) has a Financial Flexibility Index of 0.05x as of June 2023. Free cash flow of €209.53 Million (operating CF €158.72 Million minus capex €50.80 Million) represents 0% of total liabilities (€4.51 Billion). See Viva Biotech Holdings free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Viva Biotech Holdings (2016–2024)
Financial flexibility index of Viva Biotech Holdings from 2016 to 2024. Historical Financial Flexibility Index trend for Viva Biotech Holdings across 9 annual periods. Check VB0 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Viva Biotech Holdings Financial Flexibility Index by Year (2016–2024)
Viva Biotech Holdings financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Viva Biotech Holdings. For the full cash flow conversion analysis, see Viva Biotech Holdings cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.17x | €565.66 Million | €373.99 Million | €3.23 Billion | ▲ +15.2% |
| 2023 | 0.15x | €571.24 Million | €383.40 Million | €3.76 Billion | ▲ +3.1% |
| 2022 | 0.15x | €635.38 Million | €386.05 Million | €4.32 Billion | ▼ -5.4% |
| 2021 | 0.16x | €643.01 Million | €77.83 Million | €4.13 Billion | ▲ +7.6% |
| 2020 | 0.14x | €635.80 Million | €43.18 Million | €4.40 Billion | ▼ -82.8% |
| 2019 | 0.84x | €102.20 Million | €46.01 Million | €121.39 Million | ▲ +296.5% |
| 2018 | 0.21x | €59.01 Million | €12.11 Million | €277.90 Million | ▼ -77.5% |
| 2017 | 0.94x | €46.81 Million | €27.89 Million | €49.64 Million | ▼ -16.1% |
| 2016 | 1.12x | €28.46 Million | €21.12 Million | €25.32 Million | — |